GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/IBD/Diet and IBD Flares: Gut | July 2026
5

Diet and IBD Flares: Gut | July 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2026

Introduction:

Patients with inflammatory bowel disease (IBD) frequently ask whether diet influences disease relapse, yet high-quality prospective evidence has been scarce. The multicenter PREdiCCt study evaluated the impact of demographic, clinical, and habitual dietary factors on future disease flares in patients with Crohn's disease and ulcerative colitis who were in remission.

Why was this study needed?

  • Evidence linking habitual diet to IBD relapse has been limited and inconsistent.
  • Most previous studies were cross-sectional or focused on exclusive enteral nutrition rather than routine dietary habits.
  • Dietary counselling remains one of the most common unmet needs in IBD care.
  • Reliable predictors of disease relapse beyond symptoms are needed.
  • Identifying modifiable lifestyle factors may help maintain long-term remission.

Results:

  • Baseline fecal calprotectin was the strongest predictor of future relapse, with progressively increasing flare risk as fecal calprotectin levels increased.
  • Higher habitual total meat intake nearly doubled the risk of objectively confirmed flare in ulcerative colitis, independent of demographic, clinical, and biochemical factors.
  • No consistent association was observed between flare risk and ultraprocessed foods, dietary fibre, or polyunsaturated fatty acid intake, suggesting these dietary components were not major determinants of relapse in this cohort.

Clinical Impact:

This landmark prospective study provides the strongest evidence to date that habitual meat consumption is a potentially modifiable risk factor for relapse in ulcerative colitis, while reaffirming fecal calprotectin as the most powerful biomarker for predicting future disease activity. These findings support incorporating objective biomarker monitoring and individualized dietary counselling into routine IBD management.

Bottom Line:

Among patients with ulcerative colitis in remission, higher habitual meat intake was associated with an increased risk of future disease flare, whereas ultraprocessed foods, fibre, and polyunsaturated fatty acids showed no consistent relationship with relapse. Fecal calprotectin remains the single best predictor of future IBD flares.

Related Q&A

06

Stopping Thiopurines After Starting Anti-TNF Therapy: CGH | July 2026

Introduction: Combination therapy with anti–tumor necrosis factor (anti-TNF) agents and thiopurines improves treatment efficacy in inflammatory bowel disease (IBD), but long-term thiopurine use raises concerns regarding infection and...

07

Clinical Guideline Update: Management of Ulcerative Colitis in Adults from updated ACG Clinical Guideline: JAMA | July 2026

Introduction: Ulcerative colitis (UC) is a chronic inflammatory disease characterized by relapsing and remitting colonic inflammation. The updated 2025 American College of Gastroenterology (ACG) Guideline emphasizes treat-to-target management,...

08

Alcohol Metabolism Determines IBD Risk: Gut | July 2026

Introduction: The relationship between alcohol consumption and inflammatory bowel disease (IBD) has remained controversial. This large prospective study demonstrates that the effect of alcohol depends on an individual's...

09

Intestinal Ultrasound for Monitoring IBD: JCC | July 2026

Introduction: Endoscopy remains the gold standard for assessing inflammatory bowel disease (IBD) activity but is invasive, costly, and resource-intensive. This real-world study evaluated whether integrating intestinal ultrasound (IUS)...

10

Beta-Glucan and Inulin in Crohn's Disease prevention: Gastroenterology | July 2026

Introduction: Diet plays an important role in the development of Crohn's disease (CD), but the effects of specific dietary fiber subtypes remain unclear. This prospective study evaluated whether...

11

Digital Twins in IBD: Gut | July 2026

Introduction: Clinical trials in inflammatory bowel disease (IBD) are becoming increasingly expensive, complex, and difficult to conduct. This review explores the emerging role of digital twins—virtual, data-driven replicas...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer